# OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults

> **NCT05452694** · — · RECRUITING · sponsor: **OpalGenix, Inc** · enrollment: 235 (estimated)

## Conditions studied

- Lumbar Spine Stenosis
- Lumbar Spine Degeneration

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05452694
- **Lead sponsor:** OpalGenix, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2025-07-18
- **Final completion:** 2027-07-01
- **Target enrollment:** 235 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05452694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05452694, "OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05452694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*